Survival of Patients with Recurrent Malignant Glioma Treated with Temozolomide: A Retrospective Observational Study

Author： Trippoli S. Pelagotti F. Messori A. Vacca F. Vaiani M. Maltoni S.

ISSN： 1174-5886

Source： Drugs in R&D, Vol.4, Iss.5, 2003-01, pp. : 285-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 2926-2932

Blackwell Publishing

Access to resources Recommend Favorite

Vaccination with fusion cells plus edodekin alfa may be of benefit in patients with recurrent malignant glioma

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Retrospective Study of Outcomes in Hyalgan-Treated Patients with Osteoarthritis of the Knee

By Barrett J.P.

Clinical Drug Investigation, Vol. 22, Iss. 2, 2002-01 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite

Phase II Study of Antineoplaston A10 and AS2-1 in Patients with Recurrent Diffuse Intrinsic Brain Stem Glioma: A Preliminary Report

By Burzynski S.R.

Drugs in R&D, Vol. 4, Iss. 2, 2003-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Factors Associated with Bleeding in Elderly Hospitalized Patients Treated with Enoxaparin Sodium: A Prospective, Open-Label, Observational Study

By Levin Avi

Drugs & Aging, Vol. 26, Iss. 1, 2009-01 ,pp. : 77-85

Adis International

Access to resources Recommend Favorite